The present invention relates to compounds and pharmaceutical compositions
which are proteonaimetic and to methods for inhibiting the interaction of
an alpha-helical protein with another protein or binding site. Methods
for treating diseases or conditions which are modulated through
interactions between alpha helical proteins and their binding sites are
other aspects of the invention. In particular, the invention relates to
treatment of viral infections using terphenyl derivatives.